79 related articles for article (PubMed ID: 3602917)
1. Distribution of the increased cardiac output secondary to the vasodilating and inotropic effects of secretin.
Gunnes P; Reikerås O
Scand J Clin Lab Invest; 1987 Jun; 47(4):383-8. PubMed ID: 3602917
[TBL] [Abstract][Full Text] [Related]
2. Peripheral distribution of the increased cardiac output by secretin during acute ischemic left ventricular failure.
Gunnes P; Reikerås O
J Pharmacol Exp Ther; 1988 Mar; 244(3):1057-61. PubMed ID: 3252022
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of secretin infusion in man.
Gunnes P; Waldum HL; Rasmussen K; Ostensen H; Burhol PG
Scand J Clin Lab Invest; 1983 Nov; 43(7):637-42. PubMed ID: 6658378
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs.
Di Francesco GF; Baldoli E; Marchetti G; Glässer A
Arzneimittelforschung; 1986; 36(1):84-8. PubMed ID: 3954821
[TBL] [Abstract][Full Text] [Related]
5. Effects of papaveroline-monosulphate on the systemic and regional circulation in the dog.
Data PG; Rolfo A; Cacchio M; Di Tano G
Farmaco Sci; 1981 Apr; 36(4):302-14. PubMed ID: 7250364
[TBL] [Abstract][Full Text] [Related]
6. Secretin infusion in acute ischemic left ventricular failure: effects on myocardial performance and metabolism in a closed-chest dog model.
Gunnes P; Reikerås O; Lygren I
J Pharmacol Exp Ther; 1986 Dec; 239(3):915-8. PubMed ID: 3795050
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
Guo L; Tabrizchi R
Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
[TBL] [Abstract][Full Text] [Related]
8. Regional effects of dobutamine in endotoxic shock.
De Backer D; Zhang H; Manikis P; Vincent JL
J Surg Res; 1996 Oct; 65(2):93-100. PubMed ID: 8903453
[TBL] [Abstract][Full Text] [Related]
9. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
10. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
[TBL] [Abstract][Full Text] [Related]
11. Effects of secretin infusion on myocardial performance and metabolism in the dog.
Gunnes P; Smiseth OA; Lygren I; Jorde R
J Cardiovasc Pharmacol; 1985; 7(6):1183-7. PubMed ID: 2418308
[TBL] [Abstract][Full Text] [Related]
12. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
Vatner SF; McRitchie RJ; Braunwald E
J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of S-nitrosocysteine, an intravenous regional vasodilator.
Stuesse DC; Giraud GD; Vlessis AA; Starr A; Trunkey DD
J Thorac Cardiovasc Surg; 2001 Aug; 122(2):371-7. PubMed ID: 11479512
[TBL] [Abstract][Full Text] [Related]
14. Effects of high doses of insulin on systemic haemodynamics and regional blood flows in dogs.
Reikerås O; Gunnes P
Clin Physiol; 1986 Apr; 6(2):129-38. PubMed ID: 3514087
[TBL] [Abstract][Full Text] [Related]
15. Regional blood flow and cardiac responses to hydralazine.
Spokas EG; Wang HH
J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
[No Abstract] [Full Text] [Related]
16. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
[TBL] [Abstract][Full Text] [Related]
17. Effects of hydralazine on liver blood flow in normovolemic dogs.
Saretok T; Almersjö O; Biber B; Gustavsson B; Hasselgren PO
Acta Chir Scand; 1984; 150(1):1-4. PubMed ID: 6702386
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic profile of the antihypertensive vasodilator cadralazine in conscious dogs.
Dorigotti L; Ferni G; Lombroso M; Semeraro C
Arzneimittelforschung; 1984; 34(9):984-7. PubMed ID: 6542375
[TBL] [Abstract][Full Text] [Related]
19. Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance.
Dämmgen J; Kadatz R; Diederen W
Arzneimittelforschung; 1981; 31(1a):151-4. PubMed ID: 7195209
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
